Search Results - "BASH, Lori D"

Risk Implications of the New CKD Epidemiology Collaboration (CKD-EPI) Equation Compared With the MDRD Study Equation for Estimated GFR: The Atherosclerosis Risk in Communities (ARIC) Study by Matsushita, Kunihiro, MD, PhD, Selvin, Elizabeth, PhD, MPH, Bash, Lori D., MPH, PhD, Astor, Brad C., PhD, MPH, Coresh, Josef, MD, PhD

“…Background The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) recently published an equation for estimated glomerular filtration rate (eGFR) using…”
Get full text

Does deep neuromuscular blockade during laparoscopy procedures change patient, surgical, and healthcare resource outcomes? A systematic review and meta-analysis of randomized controlled trials by Raval, Amit D, Deshpande, Sohan, Rabar, Silvia, Koufopoulou, Maria, Neupane, Binod, Iheanacho, Ike, Bash, Lori D, Horrow, Jay, Fuchs-Buder, Thomas

“…Deep neuromuscular blockade may facilitate the use of reduced insufflation pressure without compromising the surgical field of vision. The current evidence,…”
Get full text

Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe by Ferrieres, Jean, De Ferrari, Gaetano Maria, Hermans, Michel P., Elisaf, Moses, Toth, Peter P., Horack, Martin, Brudi, Philippe, Lautsch, Dominik, Bash, Lori D., Baxter, Carl A., Ashton, Veronica, Ambegaonkar, Baishali, Gitt, Anselm K.

“…Background Patients with coronary heart disease (CHD) and survivors of acute coronary syndrome (ACS) are at very high risk for adverse cardiovascular events…”
Get full text

Risk of Incident ESRD: A Comprehensive Look at Cardiovascular Risk Factors and 17 Years of Follow-up in the Atherosclerosis Risk in Communities (ARIC) Study by Bash, Lori D., PhD, MPH, Astor, Brad C., PhD, MPH, Coresh, Josef, MD, PhD, MHS

“…Background Diabetes and hypertension are potent risk factors for end-stage renal disease (ESRD). Previous studies suggest that other cardiovascular risk…”
Get full text

Heart Rate Variability Predicts ESRD and CKD-Related Hospitalization by BROTMAN, Daniel J, BASH, Lori D, QAYYUM, Rehan, CREWS, Deidra, WHITSEL, Eric A, ASTOR, Brad C, CORESH, Josef

“…Autonomic imbalance, a feature of both diabetes and hypertension, may contribute to adverse cardiovascular outcomes. In animal models, sympathetic nerve…”
Get full text

Inflammation, Hemostasis, and the Risk of Kidney Function Decline in the Atherosclerosis Risk in Communities (ARIC) Study by Bash, Lori D., MPH, Erlinger, Thomas P., MD, MPH, Coresh, Josef, MD, PhD, Marsh-Manzi, Jane, PhD, Folsom, Aaron R., MD, MPH, Astor, Brad C., PhD, MPH

“…Background Inflammation and hemostasis may increase the risk of kidney function decline; however, data from prospective studies are sparse. Study Design The…”
Get full text

Trends in the use of neuromuscular blocking agents, reversal agents and neuromuscular transmission monitoring: a single-centre retrospective cohort study by Krijtenburg, Piet, de Boer, Arjen, Bash, Lori D, Scheffer, Gert Jan, Keijzer, Christiaan, Warlé, Michiel C

“…Residual neuromuscular blockade (rNMB) remains a persistent and preventable problem, with serious risks. Our objective was to describe and assess patterns in…”
Get full text

Treatment patterns of patients with worsening heart failure with reduced ejection fraction by Greene, Stephen J., Gaggin, Hanna K., Zhou, Mo, Bash, Lori D., Lautsch, Dominik, Djatche, Laurence, Song, Yan, Signorovitch, James, Stevenson, Andra S., Blaustein, Robert O., Butler, Javed

“…Aims Patients with HFrEF and worsening HF events (WHFE) are at particularly high risk and urgently need disease‐modifying therapy. CHART‐HF assessed treatment…”
Get full text

Contemporary outpatient management of patients with worsening heart failure with reduced ejection fraction: Clinical outcome results from the CHART-HF study by Gaggin, Hanna K., Greene, Stephen J., Zhou, Mo, Lautsch, Dominik, Bash, Lori D., Djatche, Laurence, Song, Yan, Signorovitch, James, Stevenson, Andra S., Blaustein, Robert O., Butler, Javed

“…Based on available data from randomized clinical trials, patients with heart failure with reduced ejection fraction (HFrEF) and worsening HF events (WHFE) have…”
Get full text

Variations in Perioperative Warfarin Management: Outcomes and Practice Patterns at Nine Hospitals by Jaffer, Amir K., MD, Brotman, Daniel J., MD, Bash, Lori D., PhD, Mahmood, Syed K., MD, Lott, Brooke, BA, White, Richard H., MD

“…Abstract Background Before surgery, most patients receiving oral anticoagulation require temporary cessation of treatment. Physicians sometimes substitute…”
Get full text

Overtreatment and Undertreatment With Anticoagulation in Relation to Cardioversion of Atrial Fibrillation (the RHYTHM-AF Study) by Lip, Gregory Y.H., MD, Gitt, Anselm K., MD, Le Heuzey, Jean-Yves, MD, Bash, Lori D., PhD MPH, Morabito, Christopher J., MD, Bernhardt, Alexandra A., PhD, Sisk, Christine McCrary, BS, Chazelle, François, MD, Crijns, Harry J., MD PhD

“…Antithrombotic therapy is central to the management of atrial fibrillation. This analysis from the RHYTHM-atrial fibrillation (RHYTHM-AF) registry explored the…”
Get full text

International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Committee by Mok, Yejin, Ballew, Shoshana H, Bash, Lori D, Bhatt, Deepak L, Boden, William E, Bonaca, Marc P, Carrero, Juan Jesus, Coresh, Josef, D'Agostino, Sr, Ralph B, Elley, C Raina, Fowkes, F Gerry R, Jee, Sun Ha, Kovesdy, Csaba P, Mahaffey, Kenneth W, Nadkarni, Girish, Peterson, Eric D, Sang, Yingying, Matsushita, Kunihiro

“…The Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention (TRS2°P), a 0-to-9-point system based on the presence/absence of 9…”
Get full text

Cardiovascular Risk Factors and Secondary Events Among Acute and Chronic Stable Myocardial Infarction Patients: Findings from a Managed Care Database by Bash, Lori D., White, Kellee, Patel, Mehul D., Liu, Jinan, Mavros, Panagiotis, Mahaffey, Kenneth W.

“…Introduction Long-term risk for recurrent cardiovascular events among myocardial infarction (MI) patients in the acute versus chronic stable phase is not well…”
Get full text

Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis by Kheterpal, Sachin, Vaughn, Michelle T., Dubovoy, Timur Z., Shah, Nirav J., Bash, Lori D., Colquhoun, Douglas A., Shanks, Amy M., Mathis, Michael R., Soto, Roy G., Bardia, Amit, Bartels, Karsten, McCormick, Patrick J., Schonberger, Robert B., Saager, Leif

“…BACKGROUND:Five percent of adult patients undergoing noncardiac inpatient surgery experience a major pulmonary complication. The authors hypothesized that the…”
Get full text

Neuromuscular Blockade and Reversal Practice Variability in the Outpatient Setting: Insights From US Utilization Patterns by Bash, Lori D., Black, Wynona, Turzhitsky, Vladimir, Urman, Richard D.

“…Neuromuscular blockade (NMB) is a critical part of many surgical procedures. Data on practice patterns of NMB agents (NMBAs) and NMB reversal in recent years…”
Get full text

Change in Estimated GFR Associates with Coronary Heart Disease and Mortality by MATSUSHITA, Kunihiro, SELVIN, Elizabeth, BASH, Lori D, FRANCESCHINI, Nora, ASTOR, Brad C, CORESH, Josef

“…Kidney function predicts cardiovascular and all-cause mortality, but little is known about the association of changes in estimated GFR (eGFR) with clinical…”
Get full text

A Clinical and Budgetary Impact Analysis of Introducing Sugammadex for Routine Reversal of Neuromuscular Blockade in a Hypothetical Cohort in the US by Jiang, Yiling, Bash, Lori D., Saager, Leif

“…Introduction Sugammadex rapidly reverses the effects of rocuronium- and vecuronium-induced neuromuscular blockade (NMB), offering a more complete and…”
Get full text

Contemporary data on treatment practices for low-density lipoprotein cholesterol in 6794 patients with stable coronary heart disease across the world by Gitt, Anselm K., Lautsch, Dominik, Ferrières, Jean, De Ferrari, Gaetano M., Vyas, Ami, Baxter, Carl A., Bash, Lori D., Ashton, Veronica, Horack, Martin, Almahmeed, Wael, Chiang, Fu-Tien, Poh, Kian Keong, Brudi, Philippe, Ambegaonkar, Baishali

“…DYSIS II CHD was a longitudinal, observational study in 6794 patients from 18 countries. They were attending an outpatient physician appointment for coronary…”
Get full text

Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II by Gitt, Anselm K., Lautsch, Dominik, Ferrières, Jean, De Ferrari, Gaetano M., Vyas, Ami, Baxter, Carl A., Bash, Lori D., Ashton, Veronica, Horack, Martin, Almahmeed, Wael, Chiang, Fu-Tien, Poh, Kian Keong, Brudi, Philippe, Ambegaonkar, Baishali

“…Low-density lipoprotein cholesterol (LDL-C) is a major contributor to cardiovascular disease. In the Dyslipidemia International Study II (DYSIS II), we…”
Get full text

Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings by Bash, Lori D., Turzhitsky, Vladimir, Black, Wynona, Urman, Richard D.

“…Introduction The management of neuromuscular blockade (NMB) has evolved over time and remains a critical component of general anesthesia. However, NMB use…”
Get full text